FI891120A - Benzofuro/3,2-c/kinolinfoereningar. - Google Patents

Benzofuro/3,2-c/kinolinfoereningar. Download PDF

Info

Publication number
FI891120A
FI891120A FI891120A FI891120A FI891120A FI 891120 A FI891120 A FI 891120A FI 891120 A FI891120 A FI 891120A FI 891120 A FI891120 A FI 891120A FI 891120 A FI891120 A FI 891120A
Authority
FI
Finland
Prior art keywords
kinolinfoereningar
benzofuro
Prior art date
Application number
FI891120A
Other languages
English (en)
Other versions
FI891120A0 (fi
Inventor
Tetsuhide Kamijo
Aaro Ujiie
Hiromu Harada
Naoyuki Tsutsumi
Atsushi Tsubaki
Toshiaki Yamaguchi
Hideo Nagata
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of FI891120A0 publication Critical patent/FI891120A0/fi
Publication of FI891120A publication Critical patent/FI891120A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI891120A 1988-08-30 1989-03-09 Benzofuro/3,2-c/kinolinfoereningar. FI891120A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63215755A JPH0692410B2 (ja) 1988-08-30 1988-08-30 新規なベンゾフロキノリン誘導体

Publications (2)

Publication Number Publication Date
FI891120A0 FI891120A0 (fi) 1989-03-09
FI891120A true FI891120A (fi) 1990-03-01

Family

ID=16677687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891120A FI891120A (fi) 1988-08-30 1989-03-09 Benzofuro/3,2-c/kinolinfoereningar.

Country Status (8)

Country Link
US (1) US5023261A (fi)
EP (1) EP0357172A3 (fi)
JP (1) JPH0692410B2 (fi)
KR (1) KR900003174A (fi)
AU (1) AU624361B2 (fi)
DK (1) DK91989A (fi)
FI (1) FI891120A (fi)
NO (1) NO168358C (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370760A3 (en) * 1988-11-22 1991-07-24 Kissei Pharmaceutical Co., Ltd. Benzofuro[3,2-c]quinoline compounds
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
JP2004075677A (ja) * 2002-06-21 2004-03-11 Toyama Chem Co Ltd 骨欠損治療および骨損傷の治癒促進剤
EP1883403A4 (en) * 2005-04-29 2011-02-16 Univ Ohio State Res Found KERATINOCYTE GROWTH FACTOR RECEPTOR TYROSINE-SPECIFIC INHIBITORS FOR THE PREVENTION OF CANCER METASTASE
WO2017136616A1 (en) * 2016-02-04 2017-08-10 Purdue Research Foundation Prodrugs of anticancer agents indotecan and indimitecan
US10759795B2 (en) 2016-03-15 2020-09-01 Purdue Research Foundation Aza-A-ring indenoisoquinoline topoisomerase I poisons
KR102572721B1 (ko) 2016-05-19 2023-09-01 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함한 유기 발광 소자
WO2018118852A1 (en) 2016-12-22 2018-06-28 Purdue Research Foundation Azaindenoisoquinoline compounds and uses thereof
CN110396094B (zh) * 2018-04-24 2021-10-12 华东师范大学 一种喹啉酮并杂芳环类化合物及其衍生物和合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017499A (en) * 1976-04-05 1977-04-12 Sandoz, Inc. 6H(1)-Benzopyrano(3,2-c)quinolines
JPS5413391A (en) * 1977-06-30 1979-01-31 Matsushita Electric Works Ltd Smoke sensor
JPS6048924A (ja) * 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
JPS6054379A (ja) * 1983-09-05 1985-03-28 Takeda Chem Ind Ltd 新規４ｈ−１−ベンゾピラン−４−オン誘導体，その製法および用途
JPS60132917A (ja) * 1983-12-21 1985-07-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
JPS60132976A (ja) * 1983-12-21 1985-07-16 Takeda Chem Ind Ltd 新規３−フエニル−４ｈ−１−ベンゾピラン−４−オン誘導体
JPS63101369A (ja) * 1986-10-17 1988-05-06 Mect Corp インデノキノリン系化合物、その製造法及びその化合物を有効成分とする抗癌剤
EP0293146A1 (en) * 1987-05-26 1988-11-30 Kissei Pharmaceutical Co. Ltd. Benzofuro [3,2-c] quinoline compounds
JPH02256667A (ja) * 1988-12-27 1990-10-17 Masatoshi Yamato 縮合キノリン系化合物およびその製造方法

Also Published As

Publication number Publication date
US5023261A (en) 1991-06-11
NO891027D0 (no) 1989-03-09
NO891027L (no) 1990-03-01
EP0357172A2 (en) 1990-03-07
AU3097789A (en) 1990-03-08
DK91989A (da) 1990-03-01
JPH0692410B2 (ja) 1994-11-16
EP0357172A3 (en) 1991-03-27
NO168358C (no) 1992-02-12
KR900003174A (ko) 1990-03-23
DK91989D0 (da) 1989-02-27
FI891120A0 (fi) 1989-03-09
NO168358B (no) 1991-11-04
JPH0262878A (ja) 1990-03-02
AU624361B2 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
NO900619D0 (no) Substituerte 1,3-okstiolaner.
DE68917544D1 (de) Durchsichtiges Präparat.
FI890176A0 (fi) Preventivmedel:mikrokondom.
DK330789D0 (da) Substituerede 1,7-annellerede 1 h-indazoler
DE68901250D1 (de) Golfball.
KR900700567A (ko) 2,3-디플루오로비페닐
DE69009322T2 (de) Polymerisierbare Zusammensetzung.
DE68901611D1 (de) Golfball.
DK647389A (da) Annellerede indolo(3,2-c)-lactamer
DE68907394D1 (de) Golfball.
NO893491D0 (no) 2-aza-4-(alkoksykarbonyl) spiro (4,5) dekan-3-on.
FI930964A (fi) 1,4-dioxino/2,3-b/pyridinderivat
FI891120A0 (fi) Benzofuro/3,2-c/kinolinfoereningar.
FI882465A0 (fi) Benzofuro (3,2-c) kinolinfoereningar.
DE58903154D1 (de) 2,2-difluorcyclopropyl-derivate.
FI894455A0 (fi) 1,4-dihydropyridinderivat.
FI880284A0 (fi) Cykloalkan /1,2-c:4,3-c'/dipyrazoler.
DE59008914D1 (de) Pyridyl-methylenamino-1,2,4-triazinone.
DE3576334D1 (de) 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrde.
DE68903983T2 (de) 1,6-diazaspiro(4,4)nonan-2,7-dion-derivate.
FI891099A (fi) Tricykliska aminderivat.
FI903430A0 (fi) 5,6-dihydrospiro-/1h-indolo/3,2-c/ kinolin-6,4'-piperidiner/ och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO901836D0 (no) Konisk river.
DE59008045D1 (de) Zusammensetzungen mit Dichlormonofluorethanen.
MX9203464A (es) 1-aminometil-1,2,3,4-tetrahidronaftalenos.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: KISSEI PHARMACEUTICAL CO., LTD.